Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

Genetic features of AML in older patients can predict outcomes after stem cell transplant

Genetic features of AML in older patients can predict outcomes after stem cell transplant

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

New technique holds promise in cancer research and science studies

New technique holds promise in cancer research and science studies

Researchers discover potent next generation of drugs to fight leukemia and lymphoma

Researchers discover potent next generation of drugs to fight leukemia and lymphoma

New approach can improve the activity of CAR-T cells against blood and solid cancers

New approach can improve the activity of CAR-T cells against blood and solid cancers

A major step toward preventing GvHD in patients receiving bone marrow transplants

A major step toward preventing GvHD in patients receiving bone marrow transplants

Michigan dermatologists honored for diagnosing rare condition

Michigan dermatologists honored for diagnosing rare condition

Low-cost intervention can increase self-esteem of young cancer survivors

Low-cost intervention can increase self-esteem of young cancer survivors

Unexpected versatility of an ancient DNA repair factor revealed

Unexpected versatility of an ancient DNA repair factor revealed

Lower life expectancy with intellectual disability

Lower life expectancy with intellectual disability

Contagious cancers in the oceans much more common than once thought

Contagious cancers in the oceans much more common than once thought

UCLA scientists discover link between a protein and human blood stem cell self-renewal

UCLA scientists discover link between a protein and human blood stem cell self-renewal

Scientists discover new approach to treating incurable leukemia in children

Scientists discover new approach to treating incurable leukemia in children

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

New tool uses tiny circuits made of DNA to identify cancer cells

New tool uses tiny circuits made of DNA to identify cancer cells

Scientists develop new therapy for acute myeloid leukemia

Scientists develop new therapy for acute myeloid leukemia

Rutgers Cancer Institute researchers awarded $2.3 million in American Cancer Society grants

Rutgers Cancer Institute researchers awarded $2.3 million in American Cancer Society grants

Radiation from CT scans can increase risk of leukemia, thyroid cancer

Radiation from CT scans can increase risk of leukemia, thyroid cancer

New drug combo may improve pancreatic cancer therapy

New drug combo may improve pancreatic cancer therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.